A man with partial facial paralysis underwent months of conventional treatment. Yet one side of his face remained motionless—his smile stuck in a lopsided stillness. Most regenerative clinics would have followed a familiar protocol: an intravenous stem cell infusion. In this method, cells circulate through the bloodstream with the aim of eventually reaching the damaged nerves. At RPT Osaka Clinic, Dr. Hiromichi Nishihara took a different approach. Drawing on decades of surgical experience, he made a bold decision—directly injecting 100 million mesenchymal stem cells (MSCs) into the patient’s facial nerve and ganglion. Within two months, the once-paralyzed muscles began to move. His affected eyelid lifted. His mouth regained balance. His face came back to life. At Osaka Clinic, regenerative medicine goes beyond administering stem cells. It’s about strategy, precision and results. Dr. Nishihara—one of Japan’s most experienced regenerative medicine specialists with over 27,000 stem cell treatments—and CEO Akihiro Toda, who also served as Secretary General of the Special Certified Regenerative Medicine Committee (the backbone of regenerative medicine in Japan), run the clinic with one guiding principle – evidence-based, ethical regenerative care that improves lives. “With integrity and passion, we take responsibility for our colleagues, our society and the impact we make. By holding ourselves to the highest standards, we strive to exceed expectations and earn patient trust,” says Dr. Nishihara. But Why Use Only MSCs? MSCs are at the forefront of regenerative medicine due to their unique ability to repair, regenerate and regulate the immune response, offering hope for conditions once considered untreatable. Their multi-lineage differentiation transforms them into bone, cartilage, muscle, nerve and skin cells, making them ideal for treating neurodegenerative diseases, joint disorders and tissue damage. Unlike conventional treatments that focus on symptom management, MSC therapy works at the cellular level, targeting the root causes of degeneration and inflammation. “The idea is to reset the body’s ability to heal itself. MSCs have that potential,” says Nishihara. The method of administration, however, is critical for this potential to be fully realized. Many clinics opt for IV infusion, but this approach lacks precision, relying on passive distribution rather than targeted action....Read more